Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.2145-0.0295 (-12.09%)
At close: 04:00PM EDT
0.2209 +0.01 (+2.98%)
After hours: 04:43PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
97.323
881.705
3,937
36,144
4,822
Operating Expense
39,828
56,871
126,747
113,248
61,570
Operating Income
-39,731
-55,989
-122,810
-77,105
-56,748
Net Non Operating Interest Income Expense
-1,732
-1,830
-1,028
1,228
982.777
Other Income Expense
6,340
12,179
12,569
4,423
92.791
Pretax Income
-35,123
-45,640
-111,269
-71,454
-55,672
Net Income Common Stockholders
-35,123
-45,640
-111,269
-71,454
-55,672
Diluted NI Available to Com Stockholders
-35,123
-45,640
-111,269
-71,454
-55,672
Basic EPS
-
-0.37
-1.42
-1.12
-0.98
Diluted EPS
-
-0.37
-1.42
-1.12
-0.98
Basic Average Shares
-
122,990
78,133
63,899
57,000
Diluted Average Shares
-
122,990
78,133
63,899
57,000
Total Operating Income as Reported
-44,731
-55,989
-122,810
-77,105
-56,748
Total Expenses
39,828
56,871
126,747
113,248
61,570
Net Income from Continuing & Discontinued Operation
-35,123
-45,640
-111,269
-71,454
-55,672
Normalized Income
-29,722
-45,920
-110,568
-71,295
-55,765
Interest Income
-
-
-
1,228
982.777
Net Interest Income
-1,732
-1,830
-1,028
1,228
982.777
EBIT
-39,731
-55,989
-122,810
-77,105
-56,748
EBITDA
-38,198
-
-
-
-
Reconciled Depreciation
1,533
1,639
1,694
1,230
493.938
Net Income from Continuing Operation Net Minority Interest
-35,123
-45,640
-111,269
-71,454
-55,672
Total Unusual Items Excluding Goodwill
-5,401
279.092
-700.999
-158.62
92.791
Total Unusual Items
-5,401
279.092
-700.999
-158.62
92.791
Normalized EBITDA
-32,798
-54,629
-120,415
-75,716
-56,347
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement